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Abstract
Chronic radiation-induced colonic injury occurs in up to 20% of patients following radiotherapy. The rectum and distal
sigmoid colon are most susceptible to radiation damage, and chronic radiation proctopathy generally manifests with
anorectal pain, diarrhea, rectal bleeding, and/or anemia. Endoscopic ﬁndings include loss of mucosal vasculature, patchy
erythema, and angioectasia, which correlate with ischemic endarteritis of the submucosal arterioles, submucosal ﬁbrosis,
and angioectasia on histopathological examination. Although most patients develop symptomatic chronic radiation
proctopathy within 1–2 years after radiation exposure, they can present up to 30 years after treatment. Radiation
proctopathy, found incidentally during endoscopy, does not warrant any therapy. Argon plasma coagulation (APC) is the
mainstay of endoscopic therapy for chronic radiation proctopathy. Laser therapy and dilute formalin (2–10%) application
are associated with higher complications and are not commonly utilized. In this video presentation, endoscopic ﬁndings
are described in chronic radiation proctopathy and colopathy as well as APC therapy. This article is part of an expert video
encyclopedia.
Keywords
Argon plasma coagulation; Endoscopy; Rectal bleeding; Radiation colopathy; Radiation proctopathy; Standard
endoscopy; Video.
Video Related to this Article
Material
Colonoscopes: Olympus CF and PCF-Q180; Olympus Amer-
ica, Center Valley, PA, USA.
Background and Endoscopic Procedure
Chronic radiation-induced colonic injury occurs in up to 20%
of patients following radiotherapy. The rectum and distal
sigmoid colon are most susceptible to radiation damage. This
is likely due to the relative immobility of these segments and
higher doses of radiation used for pelvic neoplasms. The term
‘radiation proctitis’ is a misnomer, because there is no in-
ﬂammatory component on histopathological examination.
Radiation induces ischemic endarteritis of the submucosal
arterioles, submucosal ﬁbrosis, and angioectasia. Endo-
scopically, loss of mucosal vasculature, patchy erythema, and
angioectasia can be observed. During endoscopy, mucosal
erythema and submucosal hemorrhage from barotrauma can
mimic angioectasia.
Acute radiation may cause diarrhea and tenesmus in up to
50% of the patients. Chronic radiation proctopathy presents
with anorectal pain, diarrhea, rectal bleeding, and anemia.
Although most patients develop symptomatic chronic radi-
ation proctopathy within 1–2 years after radiation exposure,
they can present up to 30 years after treatment. Rectal bleeding
is rarely life threatening and it resolves spontaneously in
majority of cases. Radiation proctopathy found incidentally
during endoscopy does not warrant any therapy.
In patients with mild symptoms, conservative therapy
consisting of rectal instillation of sucralfate has been shown
to result in symptom improvement and healing. 5-amino-
salicylic acid enemas and short-chain fatty acid enemas have
no proven efﬁcacy. In a systematic review, hyperbaric oxygen
was shown to be associated with signiﬁcant improvement
in chronic radiation proctopathy. Endoscopic treatment op-
tions include: (1) thermal coagulation with argon plasma
coagulation (APC), bipolar or heater probes, or radio-
frequency devices; (2) cryotherapy; (3) neodymium:yttrium–
aluminum–garnet (Nd:YAG) laser; and (4) topical appli-
cation of formalin. APC is the mainstay of endoscopic ther-
apy for chronic radiation proctopathy, given its tangential
application ability, ease of use on retroﬂexed view, wide-
spread availability, low cost, and clinical effectiveness. APC is
80–90% effective in decreasing rectal bleeding. In most cases,
1–3 treatment sessions are required. Complete bowel prep-
aration is recommended before APC application. Power set-
tings of 25–60 W and argon plasma ﬂow rates of
0.5–2.5 l min1 have been reported. If APC is not available,
thermal coagulation with bipolar or heater probes can be
performed. Gentle mucosal contact with 1–2-s thermal ap-
plication is recommended, but applying therapy on retro-
ﬂexed view with bipolar or heater probes may present
technical difﬁculties. Cryotherapy and radio frequency ab-
lation are novel and there is very limited data. Both devices
are not widely available or cost-effective yet. Laser therapy
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
Video Journal and Encyclopedia of GI Endoscopy 307
Video available to view or download at doi:10.1016/S2212- 
0971(13)70133-X 
http://dx.doi.org/10.1016/S2212-0971(13)70133-X 
Open access under CC BY-NC-ND license.
delivers a deeper tissue effect compared to APC, but is not
widely practiced due to its cost, variable degrees of coagu-
lation depth, and a higher risk of perforation. Dilute formalin
(2–10%) can be locally applied endoscopically. In one study,
an average of 3.5 applications of 10% formalin at 2–4 week
interval yielded clinical response rates of 63–100%. However,
complications such as rectal necrosis, rectovaginal ﬁstula de-
velopment, and acute colitis have been reported.
Key Learning Points/Tips and Tricks
• Chronic radiation-induced colonic injury occurs in up to
20% of patients following radiotherapy.
• The rectum and distal sigmoid colon are most susceptible
to radiation damage.
• During endoscopy, loss of mucosal vasculature, patchy
erythema, and angioectasia can be observed.
• Patients with chronic radiation proctopathy can present
with anorectal pain, diarrhea, rectal bleeding, and anemia.
• Although most patients develop symptomatic chronic ra-
diation proctopathy within 1–2 years after radiation, they
may present up to 30 years after treatment.
• Radiation proctopathy found incidentally on endoscopy
does not warrant therapy.
• Rectal bleeding is rarely life threatening and it resolves
spontaneously in majority of cases.
• Endoscopic treatment modalities include:
J Thermal coagulation
– APC
– Bipolar or heater probes
– Radiofrequency devices
J Cryotherapy
J Nd:YAG laser
J Topical application of formalin
• APC is the mainstay of endoscopic therapy for chronic
radiation proctopathy, with a decrease in rectal bleeding in
80–90% of patients.
• Power settings of 25–60 W and argon plasma ﬂow rates of
0.5–2.5 l min1 have been reported. In general, 1–3 APC
treatment sessions are required to achieve clinical response.
Scripted Voiceover
Time
(min:sec)
Voiceover text
00:02 The rectum and distal sigmoid colon are most susceptible
to radiation damage.
00:10 Radiation induces ischemic endarteritis of the submucosal
arterioles, submucosal ﬁbrosis, and angioectasia.
00:24 In this histopathological image, ischemic endarteritis and
angioectasia can be seen.
00:39 Submucosal ﬁbrosis is diffusely present.
00:51 In this patient with chronic radiation proctopathy, loss of
mucosal vasculature, patchy erythema, and angioectasia
are observed.
01:07 The mucosal vasculature is more preserved in the upper
rectum.
01:18 The angioectasia is better deﬁned under digital
chromoendoscopy (i.e., narrow band imaging).
01:42 In order to appreciate the full extent of rectal involvement,
retroﬂexed examination of the rectum is necessary.
01:58 Active bleeding from the angioectasia can sometimes be
seen during endoscopic examination.
02:08 Active oozing can present as a punctate bleeding spot due
to under-ﬁll of the periphery angioectasia.
02:20 Endoscopic hemostasis can generally be achieved with
thermal ablation using argon plasma coagulation (APC),
bipolar or heater probes.
02:35 APC is the mainstay of endoscopic therapy for chronic
radiation proctopathy, given its tangential application
ability, ease of use on retroﬂexed view, widespread
availability, low cost, and clinical effectiveness.
02:59 APC is 80%–90% effective in reducing rectal bleeding.
02:08 In most cases, 1–3 treatment sessions are required.
02:15 During APC treatment, gentle mucosal contact with 1–2 s
thermal application is recommended.
02:30 In this patient, chronic radiation colopathy involves the
distal sigmoid colon and rectum.
02:57 During endoscopy, mucosal erythema, and submucosal
hemorrhage from barotrauma can mimic angioectasia.
04:15 Thank you for your attention.
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